Skip to Content

93 8164 (Quetiapine Fumarate 300 mg)

Pill with imprint 93 8164 is Yellow, Capsule-shape and has been identified as Quetiapine Fumarate 300 mg. It is supplied by Teva Pharmaceuticals USA Inc..

Quetiapine is used in the treatment of bipolar disorder; schizoaffective disorder; schizophrenia; depression; major depressive disorder and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy. Quetiapine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 93 8164

Quetiapine fumarate 300 mg 93 8164
Quetiapine fumarate 300 mg 93 8164
Quetiapine fumarate 300 mg 93 8164
Quetiapine fumarate 300 mg 93 8164
Quetiapine fumarate 300 mg 93 8164

Quetiapine Fumarate

Imprint
93 8164
Strength
300 mg
Color
Yellow
Size
19.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Atypical antipsychotics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA Inc.
Inactive Ingredients
silicon dioxide, calcium phosphate dihydrate dibasic, hypromellose 2910 (15 mPa.s), lactose monohydrate, magnesium stearate, microcrystalline cellulose, povidone k25, povidone k26/28, sodium starch glycolate type A potato, titanium dioxide, triacetin, ferric oxide yellow

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00093-8164 Teva Pharmaceuticals USA, Inc.
42291-0699 AvKare, Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.